Next Article in Journal
The Use of Optimal Treatment for DLBCL Is Improving in All Age Groups and Is a Key Factor in Overall Survival, but Non-Clinical Factors Influence Treatment
Next Article in Special Issue
New Insight into Therapies Targeting Angiogenesis in Hepatocellular Carcinoma
Previous Article in Journal
Wnt/β-Catenin Signaling in Liver Cancers
Previous Article in Special Issue
Ramucirumab and GSK1838705A Enhance the Inhibitory Effects of Low Concentration Sorafenib and Regorafenib Combination on HCC Cell Growth and Motility
 
 
Article

Article Versions Notes

Action Date Notes Link
article xml file uploaded 2 July 2019 14:00 CEST Original file -
article xml uploaded. 2 July 2019 14:00 CEST Update https://0-www-mdpi-com.brum.beds.ac.uk/2072-6694/11/7/927/xml
article pdf uploaded. 2 July 2019 14:00 CEST Version of Record https://0-www-mdpi-com.brum.beds.ac.uk/2072-6694/11/7/927/pdf
article supplementary file uploaded. 2 July 2019 14:00 CEST - https://0-www-mdpi-com.brum.beds.ac.uk/2072-6694/11/7/927#supplementary
article html file updated 2 July 2019 14:02 CEST Original file -
article html file updated 2 August 2019 12:55 CEST Update -
article html file updated 12 February 2020 23:44 CET Update -
article html file updated 20 July 2022 07:38 CEST Update https://0-www-mdpi-com.brum.beds.ac.uk/2072-6694/11/7/927/html
Back to TopTop